Feasibility of delivering TeleCHAT: A comprehensive high-dose aphasia treatment via telerehabilitation.
Genevieve Vuong, Jade Dignam, Clare Burns and 4 others
PMID 41004645WHAT IT FOUND
All 12 participants completed a high-dose aphasia programme delivered remotely.
Technical issues rarely stopped therapy, and support people attended most sessions. This shows the system works, but does not yet prove the treatment improves outcomes compared to standard care.
Key findings
01All 12 people with aphasia completed the TeleCHAT programme.
0298.5% of scheduled therapy sessions were successfully delivered despite technical or personal cancellations.
03Support people attended 63.2% of all delivered sessions, participating in education and therapy activities.
STILL TO COME
How it was doneWhat they foundWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study had no control group, so it cannot determine if TeleCHAT is more effective than usual care. Participants self-nominated, which may mean they were more motivated than the average patient. The study was small, with only 12 participants, and conducted in a research setting rather than typical clinical practice. The lead author was involved in developing the programme and collecting data, which could introduce bias.
Declared interests
The study was funded by the Queensland Aphasia Research Centre, which received philanthropic gifts and university strategic funding. One author was supported by a government scholarship. The authors declared no potential conflicts of interest.
The easy way to misread this
Do not assume that TeleCHAT improves aphasia outcomes better than standard care. This was a feasibility study with no control group, so it only shows the programme can be delivered remotely, not that it is effective.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →